Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A cost-effective rabbit embolic stroke bioassay: insight into the development of acute ischemic stroke therapy.

Literature DB >> 25637174

A cost-effective rabbit embolic stroke bioassay: insight into the development of acute ischemic stroke therapy.

Paul A Lapchak¹.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2015 PMID： 25637174 PMCID： PMC4359071 DOI： 10.1007/s12975-015-0386-x

Source DB: PubMed Journal: Transl Stroke Res ISSN： 1868-4483 Impact factor: 6.829

× No keyword cloud information.

66 in total

1. Should all stroke patients receive tissue plasminogen activator therapy, despite mild or improving symptoms?

Authors: Patrick D Lyden
Journal: Nat Clin Pract Cardiovasc Med Date: 2006-04

2. Sisyphus and translational stroke research.

Authors: Patrick Lyden; Paul Lapchak
Journal: Sci Transl Med Date: 2012-10-17 Impact factor: 17.956

Review 3. The use of desmoteplase (bat saliva) in the treatment of ischaemia.

Authors: Bartlomiej Piechowski-Jozwiak; Julien Bogousslavsky
Journal: Expert Opin Biol Ther Date: 2013-03 Impact factor: 4.388

4. Transcranial laser therapy in acute stroke treatment: results of neurothera effectiveness and safety trial 3, a phase III clinical end point device trial.

Authors: Werner Hacke; Peter D Schellinger; Gregory W Albers; Natan M Bornstein; Bjorn L Dahlof; Rachael Fulton; Scott E Kasner; Ashfaq Shuaib; Steven P Richieri; Stephen G Dilly; Justin Zivin; Kennedy R Lees
Journal: Stroke Date: 2014-10-07 Impact factor: 7.914

Review 5. Neuroprotective effects of anesthetic agents.

Authors: Masahiko Kawaguchi; Hitoshi Furuya; Piyush M Patel
Journal: J Anesth Date: 2005 Impact factor: 2.078

Review 6. Hemorrhagic transformation following ischemic stroke: significance, causes, and relationship to therapy and treatment.

Authors: Paul A Lapchak
Journal: Curr Neurol Neurosci Rep Date: 2002-01 Impact factor: 5.081

7. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.

Authors: Werner Hacke; Geoffrey Donnan; Cesare Fieschi; Markku Kaste; Rüdiger von Kummer; Joseph P Broderick; Thomas Brott; Michael Frankel; James C Grotta; E Clarke Haley; Thomas Kwiatkowski; Steven R Levine; Chris Lewandowski; Mei Lu; Patrick Lyden; John R Marler; Suresh Patel; Barbara C Tilley; Gregory Albers; Erich Bluhmki; Manfred Wilhelm; Scott Hamilton
Journal: Lancet Date: 2004-03-06 Impact factor: 79.321

8. Tissue plasminogen activator-mediated thrombolysis of cerebral emboli and its effect on hemorrhagic infarction in rabbits.

Authors: P D Lyden; J A Zivin; W A Clark; K Madden; K C Sasse; V A Mazzarella; R D Terry; G A Press
Journal: Neurology Date: 1989-05 Impact factor: 9.910

Review 9. Dual effects of neuroprotection and neurotoxicity by general anesthetics: role of intracellular calcium homeostasis.

Authors: Huafeng Wei; Saadet Inan
Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2013-05-28 Impact factor: 5.067

10. Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke in China.

Authors: Yuesong Pan; Qidong Chen; Xingquan Zhao; Xiaoling Liao; Chunjuan Wang; Wanliang Du; Gaifen Liu; Liping Liu; Chunxue Wang; Yilong Wang; Yongjun Wang
Journal: PLoS One Date: 2014-10-20 Impact factor: 3.240

7 in total

1. Critical early thrombolytic and endovascular reperfusion therapy for acute ischemic stroke victims: a call for adjunct neuroprotection.

Authors: Paul A Lapchak
Journal: Transl Stroke Res Date: 2015-08-29 Impact factor: 6.829

2. Cytoprotective Drug-Tissue Plasminogen Activator Protease Interaction Assays: Screening of Two Novel Cytoprotective Chromones.

Authors: Paul A Lapchak; Jacqueline M Lara; Paul D Boitano
Journal: Transl Stroke Res Date: 2017-04-12 Impact factor: 6.829